Abbott Laboratories, Stryker, and Becton Dickinson continue to raise dividends thanks to steady demand for medical devices like syringes and implants. Becton Dickinson leads with 55 consecutive years of dividend increases, supported by strong free cash flow and debt reduction. Abbott boasts 54 years of raises and plans more after spinning off its nutrition business, while Stryker offers the lowest payout ratio, allowing room for future dividend growth. These stocks provide reliable income streams for investors, even during economic slowdowns.
As of Nov 07, 2026 21:01 WIB, Abbott Laboratories trades at USD 109.93 on Pluang, down 3.23% in one day. Stryker shares are priced at USD 325.78 with a dividend yield of 1.08%, reflecting its lower payout ratio. Becton Dickinson is valued at USD 211.88, showing a modest 0.78% decline, with a dividend yield of 2% on the platform.
